Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region

Human Pathology

Volumn 36, Issue 7, 2005, Pages 724-731

  Staibano, Stefania ^a   Pepe, Stefano ^a   Muzio, Lorenzo Lo ^b   Somma, Pasquale ^a   Mascolo, Massimo ^a   Argenziano, Giuseppe ^a   Scalvenzi, Massimiliano ^a   Salvatore, Gaetano ^a   Fabbrocini, Gabriella ^a   Molea, Guido ^a   Bianco, Angelo Raffaele ^a   Carlomagno, Chiara ^a   De Rosa, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Cutaneous melanoma; PARP 1; Prognosis

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ADULT; AGED; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LIGHT EXPOSURE; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; OUTCOMES RESEARCH; PROGNOSIS; PROTEIN EXPRESSION; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; DISEASE PROGRESSION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; POLY(ADP-RIBOSE) POLYMERASES; SKIN NEOPLASMS; SURVIVAL RATE; ULTRAVIOLET RAYS;

EID: 23444443380     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.04.017     Document Type: Article

References (42)

1. R. Cabrera, S. Silva, and J. Diaz de Medina Clinical study of 113 cases of malignant melanoma Rev Med Chil 122 8 1994 900 906
2. W.A. Muller, and M. Erlanger Malignant melanoma in life insurance-thickness or anatomic layer? Versicherungsmedizin 46 6 1994 193 195
3. R.M. MacKie, C.A. Bray, and D.J. Hole Incidence of and survival from malignant melanoma in Scotland: an epidemiological study Lancet 360 9333 2002 587 591
4. R. Boni, C. Schuster, and B. Nehrhoff Epidemiology of skin cancer Neuroendocrinol Lett 23 Suppl 2 2002 48 51
5. M.M. Braun, M.A. Tucker, and S.S. Devesa Seasonal variation in frequency of diagnosis of cutaneous malignant melanoma Melanoma Res 4 4 1994 235 241
6. R. Cavalieri, V. Macchini, and S. Mostaccioli Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991 Ann Ist Super Sanita 29 3 1993 469 472
7. S. Franceschi, E. Bidoli, and S. Prati Mortality from skin melanoma in Italy and Friuli-Venezia Giulia region, 1970-1989 Tumori 80 4 1994 251 256
8. K.A. Yeh, and J.P. Wei An overview of cutaneous malignant melanoma J Med Assoc Ga 83 11 1994 635 638
9. H. Von der Maase, A. Osterlind, and K.T. Drzewiecki Malignant melanoma of the skin in Denmark-epidemiology, diagnosis and treatment Ugeskr Laeger 154 28 1992 1949 1953
10. D.D. Lawson, D.H. Moore, and J.S. Schneider Nevus counting as a risk factor for melanoma: comparison of self-count with count by physician J Am Acad Dermatol 31 3 Pt 1 1994 438 444
11. A.A. Marghoob, A.W. Kopf, and D.S. Rigel Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study Arch Dermatol 130 8 1994 993 998
12. C. Garbe Risk factors for the development of malignant melanoma and identification of risk groups in German-speaking regions Hautarzt 46 5 1995 309 314
13. M.C. Abadir, A.A. Marghoob, and J. Slade Case-control study of melanocytic nevi on the buttocks in atypical mole syndrome: role of solar radiation in the pathogenesis of atypical moles J Am Acad Dermatol 33 1 1995 31 36
14. A. Jackson, C. Wilkinson, and K. Hood Does experience predict knowledge and behavior with respect to cutaneous melanoma, moles, and sun exposure? Possible outcome measures Behav Med 26 2 2000 74 79
15. L. Bakos, M. Wagner, and R.M. Bakos Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil Int J Dermatol 41 9 2002 557 562
16. C. Jansen Effect of sunlight on the skin-what have we learned? Nord Med 110 3 1995 85 87
17. S. Schmitz, C. Garbe, and B. Tebbe Long-wave ultraviolet radiation (UVA) and skin cancer Hautarzt 45 8 1994 517 525
18. P. Autier, J.F. Dore, and F. Lejeune Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group Int J Cancer 58 6 1994 809 813
19. S. Adimoolam, and J.M. Ford p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene Proc Natl Acad Sci U S A 99 20 2002 12985 12990
20. F. Nomura, M. Yaguchi, and A. Togawa Enhancement of poly-adenosine diphosphate-ribosylation in human hepatocellular carcinoma J Gastroenterol Hepatol 15 5 2000 529 535
21. C.M. Balch, A.C. Buzaid, and M.B. Atkins Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 2001 3635 3648
22. C.M. Balch Cutaneous melanoma F.L. Greene D.L. Page I.D. Fleming AJCC cancer staging manual 6th ed. 2002 Springer Verlag New York (NY) 209 217
23. W.M. Tong, U. Cortes, and Z.Q. Wang Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis Biochim Biophys Acta 1552 1 2001 27 37
24. P. Decker, and S. Muller Modulating poly(ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress Curr Pharm Biotechnol 3 3 2002 275 283
25. X. Wang, K. Ohnishi, and A. Takahashi Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation Oncogene 17 22 1998 2819 2825
26. C. Bernstein, H. Bernstein, and C.M. Payne DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis Mutat Res 511 2 2002 145 178
27. Y.A. Lazebnik, S.H. Kaufmann, and S. Desnoyers Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE Nature 371 6495 1994 346 347
28. S.H. Kaufmann, S. Desnoyers, and Y. Ottaviano Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis Cancer Res 53 17 1993 3976 3985
29. A. Vaculova, J. Hofmanova, and K. Soucek Tumor necrosis factor-alpha induces apoptosis associated with poly(ADP-ribose) polymerase cleavage in HT-29 colon cancer cells Anticancer Res 22 3 2002 1635 1639
30. D.W. Kamp, M. Srinivasan, and S.A. Weitzman Cigarette smoke and asbestos activate poly-ADP-ribose polymerase in alveolar epithelial cells J Investig Med 49 1 2001 68 76
31. J.J. van den Oord, N. Vandeghinste, and M. De Ley Bcl-2 expression in human melanocytes and melanocytic tumors Am J Pathol 145 2 1994 294 300
32. L.H. Boise, M. Gonzalez-Garcia, and C.E. Postema bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death Cell 74 4 1993 597 608
33. H. Steller Mechanisms and genes of cellular suicide Science 267 5203 1995 1445 1449
34. C.J. Larsen The BCL2 gene, prototype of a gene family that controls programmed cell death (apoptosis) Ann Genet 37 3 1994 121 134
35. U. Leiter, R.M. Schmid, and P. Kaskel Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma Arch Dermatol Res 292 5 2000 225 232
36. J.C. Reed Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance Curr Opin Oncol 7 6 1995 541 546
37. L. Tang, V.A. Tron, and J.C. Reed Expression of apoptosis regulators in cutaneous malignant melanoma Clin Cancer Res 4 8 1998 1865 1871
38. T. Vlaykova, L. Talve, and M. Hahka-Kemppinen Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response Oncology 62 3 2002 259 268
39. H. Helmbach, M.A. Kern, and E. Rossmann Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency J Invest Dermatol 118 6 2002 923 932
40. U. Keilholz, P. Martus, and C.J. Punt Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatin Eur J Cancer 38 11 2002 1501 1511
41. W. Feleszko, I. Mlynarczuk, and D. Olszewska Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism Int J Cancer 100 1 2002 111 118
42. E.Q. Shyong, Y. Lu, and A. Lazinsky Effects of the isoflavone 4′,5,7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamage Carcinogenesis 23 2 2002 317 321